Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,454	2,125	2,883	2,283	1,987	1,479
Short-Term Investments	52.25	61.7	40.61	109.64	-	-
Trading Asset Securities	-	-	-	-	-	43.52
Cash & Short-Term Investments	3,506	2,187	2,923	2,393	1,987	1,523
Cash Growth	61.97%	-25.19%	22.16%	20.40%	30.49%	0.17%
Accounts Receivable	2,944	2,653	2,725	1,971	1,971	1,797
Other Receivables	42.37	34.1	60.77	40.73	36.63	11.44
Receivables	2,987	2,687	2,785	2,011	2,007	1,809
Inventory	1,555	1,567	1,429	1,525	1,488	1,595
Other Current Assets	119.4	111.07	107.5	495.77	121.13	208.64
Total Current Assets	8,167	6,552	7,245	6,425	5,604	5,135
Property, Plant & Equipment	1,461	1,442	1,465	1,486	1,460	1,367
Long-Term Investments	831.83	882.67	801.46	740.74	803.85	906.91
Goodwill	65.91	65.91	84.69	-	-	-
Other Intangible Assets	309.07	317.75	281.13	198.19	202.51	174.06
Long-Term Deferred Tax Assets	319.25	265.99	208.35	154.6	165.48	183.8
Long-Term Deferred Charges	18.02	18.3	17.54	4.72	8.81	8.29
Other Long-Term Assets	728.28	686.29	53.77	57.51	39.47	67.97
Total Assets	11,901	10,230	10,157	9,067	8,283	7,843
Accounts Payable	1,065	1,126	1,406	1,242	902.25	652.64
Accrued Expenses	1,878	1,493	1,170	679.77	709.16	790.64
Short-Term Debt	802.2	81.8	101.64	-	-	-
Current Portion of Long-Term Debt	23.37	-	-	30	-	-
Current Portion of Leases	2.81	3.56	4.1	1.6	1	0.96
Current Income Taxes Payable	101.07	76.68	93.28	9.53	10.49	59.36
Current Unearned Revenue	149.42	145.66	219.07	215.61	246.67	364.3
Other Current Liabilities	1,228	305.66	339.37	254.89	294.27	289.29
Total Current Liabilities	5,250	3,233	3,333	2,434	2,164	2,157
Long-Term Debt	242.25	251.03	161.3	10	40	40
Long-Term Leases	2.03	2.74	0.87	1.57	1.71	2.71
Long-Term Unearned Revenue	55.82	57.14	59.88	59.15	63.35	44.94
Long-Term Deferred Tax Liabilities	6.72	7.33	8.82	4.21	3.8	8.94
Other Long-Term Liabilities	33.48	33.69	40.73	44.42	60.78	66.17
Total Liabilities	5,590	3,585	3,605	2,553	2,333	2,320
Common Stock	770.16	770.16	773.44	773.44	773.64	772.8
Additional Paid-In Capital	975.56	975.21	1,048	1,374	1,365	1,349
Retained Earnings	4,500	4,828	4,700	4,218	3,681	3,209
Treasury Stock	-5.39	-7.04	-29.75	-32.03	-34.78	-28.3
Comprensive Income & Other	32.56	34.34	29.53	30.62	23.19	86.18
Total Common Equity	6,273	6,601	6,521	6,364	5,808	5,388
Minority Interest	38	44.55	30.49	149.35	141.49	135.03
Shareholders' Equity	6,311	6,645	6,552	6,514	5,950	5,523
Total Liabilities & Equity	11,901	10,230	10,157	9,067	8,283	7,843
Total Debt	1,073	339.14	267.91	43.17	42.71	43.67
Net Cash (Debt)	2,434	1,848	2,655	2,350	1,945	1,479
Net Cash Growth	79.83%	-30.41%	13.01%	20.83%	31.46%	17.55%
Net Cash Per Share	3.15	2.40	3.42	3.05	2.53	1.92
Filing Date Shares Outstanding	770.16	770.16	773.44	773.44	773.64	772.8
Total Common Shares Outstanding	770.16	770.16	773.44	773.44	773.64	772.8
Working Capital	2,917	3,319	3,912	3,991	3,440	2,978
Book Value Per Share	8.14	8.57	8.43	8.23	7.51	6.97
Tangible Book Value	5,898	6,217	6,156	6,166	5,606	5,214
Tangible Book Value Per Share	7.66	8.07	7.96	7.97	7.25	6.75
Buildings	1,371	1,338	1,337	1,323	1,341	1,310
Machinery	1,156	1,107	1,087	1,028	978.12	922.81
Construction In Progress	428.88	386.46	333.85	331.62	285.01	203.08

Source: S&P Capital IQ. Standard template. Financial Sources.